Log in to save to my catalogue

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways unde...

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways unde...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A258814552

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance

About this item

Full title

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance

Publisher

American Diabetes Association

Journal title

Diabetes (New York, N.Y.), 2011-06, Vol.60 (6), p.1647

Language

English

Formats

Publication information

Publisher

American Diabetes Association

More information

Scope and Contents

Contents

OBJECTIVE--Metreleptin has been efficacious in improving metabolic control in patients with lipodystrophy, but its efficacy has not been tested in obese patients with type 2 diabetes. RESEARCH DESIGN AND METHODS--We studied the role of leptin in regulating the endocrine adaptation to long-term caloric deprivation and weight loss in obese diabetic s...

Alternative Titles

Full title

Efficacy of metreleptin in obese patients with type 2 diabetes: cellular and molecular pathways underlying leptin tolerance

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_gale_infotracmisc_A258814552

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_gale_infotracmisc_A258814552

Other Identifiers

ISSN

0012-1797

DOI

10.2337/db10-1791/-/DC1

How to access this item